MedPath
PPB Approval

VANFLYTA TABLETS 26.5MG

HK-68662

Prescription only Medicines

April 25, 2025

Company Information

Company Details

SUITES 3207-11, 32/F, TOWER ONE, TIMES SQUARE, 1, MATHESON STREET, CAUSEWAY BAY, HONG KONG

Active Ingredients

quizartinib (as dihydrochloride)

Drug Monographs

Quizartinib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VANFLYTA TABLETS 26.5MG - PPB 批准文号 | MedPath